Log in

OTCMKTS:OCLG - Oncologix Tech Stock Price, Forecast & News

0.00 (0.00 %)
(As of 12/16/2019 06:25 AM ET)
Today's Range
Now: $0.00
50-Day Range N/A
52-Week Range
Now: $0.00
Volume509,415 shs
Average Volume1.67 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Oncologix Tech, Inc., a diversified medical holding company, provides health care services in the United States. It offers personal home care services, including daily living assistance, companionship, and homemaker services, as well as Alzheimer's care, home care resource planning, and medical care coordination services. The company also manufactures, markets, and distributes medical technologies and products for skilled nursing facilities, acute and critical care facilities, assisted living facilities, hospitals and medical institutions, federal agencies, home medical care industry, respiratory and therapy- physical/occupational therapy centers. In addition, it distributes and sells home medical equipment for sleep and respiratory therapies; supplies and services durable medical equipment to treat obstructive Sleep Apnea; C-PAP and BiPAP oxygen equipment, a large selection of mask interfaces; and offers personalized treatment plans, as well as monitoring and support services. The company was formerly known as BestNet Communications Corp. and changed its name to Oncologix Tech, Inc. in January 2007. Oncologix Tech, Inc. was founded in 1995 and is based in Lafayette, Louisiana.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Current SymbolOTCMKTS:OCLG



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive OCLG News and Ratings via Email

Sign-up to receive the latest news and ratings for OCLG and its competitors with MarketBeat's FREE daily newsletter.

Oncologix Tech (OTCMKTS:OCLG) Frequently Asked Questions

What is Oncologix Tech's stock symbol?

Oncologix Tech trades on the OTCMKTS under the ticker symbol "OCLG."

Has Oncologix Tech been receiving favorable news coverage?

Headlines about OCLG stock have trended negative this week, InfoTrie reports. The research firm scores the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Oncologix Tech earned a news impact score of -2.8 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Oncologix Tech.

Who are some of Oncologix Tech's key competitors?

Who are Oncologix Tech's key executives?

Oncologix Tech's management team includes the folowing people:
  • Mr. Michael A. Kramarz, Chairman, CEO, CFO & Sec. (Age 49)
  • Mr. Harold Halman, COO & Director
  • Ms. Nikole Jessie, Director of Marketing & PR
  • Mr. James C. Reed, Director of Radiation Science and Radiation Safety Officer

How do I buy shares of Oncologix Tech?

Shares of OCLG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Oncologix Tech's stock price today?

One share of OCLG stock can currently be purchased for approximately $0.00.

How can I contact Oncologix Tech?

Oncologix Tech's mailing address is 1604 West Pinhook Road Suite # 200, Lafayette LA, 70508. The company can be reached via phone at 616-977-9933.

MarketBeat Community Rating for Oncologix Tech (OTCMKTS OCLG)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  40 (Vote Outperform)
Underperform Votes:  41 (Vote Underperform)
Total Votes:  81
MarketBeat's community ratings are surveys of what our community members think about Oncologix Tech and other stocks. Vote "Outperform" if you believe OCLG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OCLG will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel